Pomegranate Health Cloud's application for an IPO in the United States has been filed.
Pomegranate Cloud Healthcare is going to the United States for an IPO and has been approved.
On January 17, the China Securities Regulatory Commission issued the "Notice on the Overseas Issuance and Listing Filing of POMDOCTOR LIMITED (Pomegranate Cloud Medical Co., Ltd.). Pomegranate Cloud Medical plans to issue no more than 1,007,113 common shares and list on the Nasdaq Stock Exchange in the United States.
Related Articles
Miwei Biology-B (02493) starts its IPO today, with cornerstone investors Junshi Bio, Guilin Sanjin Pharmaceutical and Wuxi Bio subscribing to US$53 million worth of shares.
Subscription of A-shares | Zhongke Instrument (920186.BJ) starts subscription, focusing on the research and development of clean vacuum and ultra-high vacuum technology.
YIDU TECH (02158) profit pre-announcement: Net profit for the fiscal year 2026 is expected to be between 55 million and 70 million yuan. "AI orders" are strong.
Miwei Biology-B (02493) starts its IPO today, with cornerstone investors Junshi Bio, Guilin Sanjin Pharmaceutical and Wuxi Bio subscribing to US$53 million worth of shares.
Subscription of A-shares | Zhongke Instrument (920186.BJ) starts subscription, focusing on the research and development of clean vacuum and ultra-high vacuum technology.
YIDU TECH (02158) profit pre-announcement: Net profit for the fiscal year 2026 is expected to be between 55 million and 70 million yuan. "AI orders" are strong.
RECOMMEND
Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026
Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026
Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026
